A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : sRAGE

Search Conditions:
Search Keyword : sRAGE
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: sRAGE
Appearance Frequency: 657 time(s)
Long forms: 22

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
soluble receptor for advanced glycation end products
(332 times)
Vascular Diseases
(30 times)
AGEs (27 times)
HMGB1 (25 times)
RAGE (24 times)
2001 [Antioxidant and anti-AGE therapeutics: evaluation and perspectives].
soluble RAGE
(203 times)
Vascular Diseases
(25 times)
RAGE (150 times)
AGEs (57 times)
esRAGE (33 times)
2000 Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice.
soluble form of RAGE
(50 times)
Metabolism
(8 times)
RAGE (31 times)
AGEs (20 times)
esRAGE (7 times)
1995 The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.
soluble receptor for AGEs
(45 times)
Metabolism
(7 times)
AGEs (33 times)
AGE (9 times)
RAGE (6 times)
2003 The role of advanced glycation end products in retinal microvascular leukostasis.
soluble form of receptor for AGE
(5 times)
Endocrinology
(2 times)
AGEs (2 times)
AGE (1 time)
CVD (1 time)
2008 Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
soluble RAGE form
(4 times)
Biochemistry
(3 times)
RAGE (4 times)
ADMA (2 times)
PG (2 times)
2007 Soluble RAGE in type 2 diabetes: association with oxidative stress.
serum-soluble RAGE
(2 times)
Neurology
(1 time)
RAGE (2 times)
ALS (1 time)
DR (1 time)
2009 Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis.
soluble advanced glycation end products
(2 times)
Medicine
(1 time)
MPO (2 times)
sCD40L (2 times)
DBP (1 time)
2012 Evaluation of emerging biomarkers in cardiovascular risk stratification of hypertensive patients: a 2-year study.
plasma-soluble RAGE
(1 time)
Respiratory Tract Diseases
(1 time)
CI (1 time)
ILD (1 time)
IPF (1 time)
2017 Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis.
10  secreted soluble isoform of RAGE
(1 time)
Endocrinology
(1 time)
AGEs (1 time)
HMGB1 (1 time)
RAGE (1 time)
2018 
11  secretory RAGE
(1 time)
Biomedical Research
(1 time)
esRAGE (1 time)
2016 Diagnostic Potential of Evaluation of SDF-1alpha and sRAGE Levels in Threatened Premature Labor.
12  serum AGEs, total RAGE
(1 time)
Geriatrics
(1 time)
AGEs (1 time)
CI (1 time)
CML (1 time)
2009 Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.
13  shed RAGE
(1 time)
Biochemistry
(1 time)
esRAGE (1 time)
RAGE (1 time)
2013 Statins stimulate the production of a soluble form of the receptor for advanced glycation end products.
14  Soluble Advanced Glycation End Products Receptor
(1 time)
Chemistry
(1 time)
AGEs (1 time)
2016 Generation of Soluble Advanced Glycation End Products Receptor (sRAGE)-Binding Ligands during Extensive Heat Treatment of Whey Protein/Lactose Mixtures Is Dependent on Glycation and Aggregation.
15  soluble AGE receptor
(1 time)
Chemistry
(1 time)
AGEs (1 time)
2016 Generation of Soluble Advanced Glycation End Products Receptor (sRAGE)-Binding Ligands during Extensive Heat Treatment of Whey Protein/Lactose Mixtures Is Dependent on Glycation and Aggregation.
16  Soluble circulating RAGE
(1 time)
Endocrinology
(1 time)
AGEs (1 time)
ARIC (1 time)
RAGEs (1 time)
2013 sRAGE and risk of diabetes, cardiovascular disease, and death.
17  soluble extracellular part of RAGE
(1 time)
Biochemistry
(1 time)
RAGE (1 time)
2007 Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches.
18  soluble form of the AGE receptor
(1 time)
Endocrinology
(1 time)
esRAGE (1 time)
RAGE (1 time)
2007 Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes.
19  soluble form of the Receptor of Advanced Glycosylated End-products
(1 time)
Biochemistry
(1 time)
--- 2016 Circulating sRAGE in the diagnosis of osteolytic bone metastasis.
20  soluble receptor AGE levels
(1 time)
Vascular Diseases
(1 time)
AF (1 time)
AGE (1 time)
AGEs (1 time)
2015 Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease.
21  splice variant C-truncated RAGE
(1 time)
Nephrology
(1 time)
ACEI (1 time)
AGE (1 time)
RAGE (1 time)
2005 Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.
22  sRAGE levels and detect
(1 time)
Medicine
(1 time)
ALI (1 time)
PICUs (1 time)
2018 Diagnostic indicator of acute lung injury for pediatric critically ill patients at a tertiary pediatric hospital.